What dose of prednisolone should I give to a 16-year-old female with an acute asthma exacerbation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 22, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Prednisolone Dosing for a 16-Year-Old with Acute Asthma Exacerbation

For a 16-year-old female with an acute asthma exacerbation, prescribe prednisolone 40–60 mg once daily for 5–10 days without tapering, continuing until peak expiratory flow reaches ≥70% of predicted or her personal best. 1

Dosing Algorithm Based on Severity

Moderate Exacerbation

  • If the patient can speak in sentences, has respiratory rate <25/min, pulse <110/min, and SpO₂ >92% on room air: Start prednisolone 40 mg once daily 1
  • Peak expiratory flow typically 40–69% of predicted 1

Severe Exacerbation

  • If the patient has difficulty completing sentences, respiratory rate ≥25/min, pulse ≥110/min, or oxygen desaturation: Use prednisolone 60 mg once daily 1
  • Peak expiratory flow <50% of predicted 1
  • Consider adding ipratropium bromide 0.5 mg to nebulized bronchodilators 2

Life-Threatening Features

  • If peak flow <33% predicted, silent chest, confusion, exhaustion, or cyanosis present: Give prednisolone 60 mg immediately OR switch to IV hydrocortisone 200 mg, then 200 mg every 6 hours 2, 1
  • Arrange immediate intensive care consultation 2

Route Selection

Oral prednisolone is strongly preferred and equally effective as intravenous therapy when the patient can swallow and has intact gastrointestinal absorption. 1, 3, 4 Reserve IV hydrocortisone only for patients who are actively vomiting, severely ill, or unable to tolerate oral medication. 1

Duration and Tapering

  • Continue treatment for 5–10 days until peak expiratory flow reaches ≥70% of predicted or personal best 1, 5
  • No tapering is required for courses lasting 5–10 days, especially when the patient is concurrently using inhaled corticosteroids 1, 6
  • Tapering short courses is unnecessary and may lead to underdosing during the critical recovery period 1

Essential Concurrent Therapy

  • Nebulized salbutamol 5 mg (or via MDI with spacer) every 20 minutes for three doses, then every 1–4 hours as needed 2, 1
  • Supplemental oxygen to maintain SpO₂ >92% 2, 1
  • Continue or initiate inhaled corticosteroids at higher doses than pre-exacerbation 1
  • Add ipratropium bromide 0.5 mg to nebulizer if not improving after 15–30 minutes 2, 1

Monitoring Response

  • Measure peak expiratory flow 15–30 minutes after starting treatment 2, 1
  • Reassess clinical status after 15–30 minutes; if no improvement, escalate care and increase bronchodilator frequency 2, 1
  • Continue monitoring peak flow at least 4 times daily throughout treatment 2

Critical Pitfalls to Avoid

  • Never delay systemic corticosteroids while giving repeated bronchodilators alone—underuse of corticosteroids is a documented cause of preventable asthma deaths 2, 1
  • Do not use doses higher than 60 mg—higher doses provide no additional benefit but increase adverse effects 1, 7
  • Do not use weight-based dosing in adolescents—the standard 40–60 mg range applies regardless of body weight 1
  • Never administer sedatives—they are contraindicated and potentially fatal in acute asthma 2
  • Do not rely on clinical impression alone—always measure peak expiratory flow objectively 2, 1

Discharge Planning

Before discharge, ensure:

  • Patient has been stable on discharge medications for ≥24 hours 2, 1
  • Peak flow >75% of predicted with diurnal variability <25% 2, 1
  • Inhaler technique verified and documented 2, 1
  • Written asthma action plan provided 2, 1
  • Peak flow meter prescribed 2, 1
  • Follow-up arranged with primary care within 1 week and respiratory specialist within 4 weeks 2, 1

References

Guideline

Corticosteroid Dosing for Asthma Exacerbations

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Oral versus intravenous steroids in acute exacerbation of asthma--randomized controlled study.

The Journal of the Association of Physicians of India, 2011

Research

Oral versus intravenous corticosteroids in children hospitalized with asthma.

The Journal of allergy and clinical immunology, 1999

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.